DAVID M. MOTT - 17 Jun 2021 Form 4 Insider Report for NOVAVAX INC (NVAX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVAX	Stock Option (Right to Buy)	Award	$0	+1,300		$0.000000	1,300	17 Jun 2021	Common Stock	1,300	$179.89	Direct	F1
transaction	NVAX	Restricted Stock Units	Award	$0	+700		$0.000000	700	17 Jun 2021	Common Stock	700		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan") will vest one (1) year from the June 17, 2021 grant date (the "Grant Date") subject to continued service on the Company's Board of Directors through the vesting date.
F2	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.
F3	One hundred percent (100%) of the RSUs subject to this grant under the Plan will vest one (1) year from the Grant Date subject to continued service on the Company's Board of Directors through the vesting date.